Literature DB >> 16819324

Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors.

David Scheie1, Per Arne Andresen, Milada Cvancarova, Anne Signe Bø, Eirik Helseth, Kari Skullerud, Klaus Beiske.   

Abstract

Combined loss of heterozygosity (LOH) on 1p and 19q is reported in 50% to 90% of oligodendroglial tumors and has emerged as a strong and favorable prognostic factor. Fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR) are the most widely used techniques. The aim of this study was to evaluate the reliability of FISH to predict LOH at 1p and 19q when performed on touch preparations from 40 oligodendroglial tumors, even if the majority of the nuclei showed chromosomal imbalance. PCR was used as the gold standard. The presence of none or one target signal was reported as FISH-LOH, whereas all other losses were defined as FISH-imbalance. The sum of nuclei with FISH-LOH and imbalance was calculated in each case (FISH-sum) and cut-off values were defined as the mean FISH-sum value in controls plus 3 standard deviations; 27.7% for 1p and 33.2% for 19q. These corresponded well with the optimal cut-off values for our data, calculated using the minimum error rate classification procedure (35.6% for 1p and 33.1% for 19q). Concurrent FISH and PCR results were encountered in 95% for 1p and 87.5% for 19q. FISH-sum was the best and simplest discriminating variable for correct classification of LOH status. Under these conditions, even a dominant population of nuclei showing FISH-imbalance represented an LOH status in the tumor cells. FISH on touch preparations is a quick and reliable method for 1p/19q testing, does not require normal DNA and can be easily performed in an immunohistochemistry unit.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819324     DOI: 10.1097/01.pas.0000213250.44822.2e

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

Review 1.  Molecular diagnostics: techniques and recommendations for 1p/19q assessment.

Authors:  Adelheid Woehrer; Johannes A Hainfellner
Journal:  CNS Oncol       Date:  2015-11-06

2.  Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.

Authors:  Anna Latysheva; Kyrre Eeg Emblem; Petter Brandal; Einar Osland Vik-Mo; Jens Pahnke; Kjetil Røysland; John K Hald; Andrés Server
Journal:  Neuroradiology       Date:  2019-02-02       Impact factor: 2.804

3.  Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.

Authors:  Irena Srebotnik-Kirbiš; Clara Limbäck-Stokin
Journal:  J Neurooncol       Date:  2016-07-12       Impact factor: 4.130

4.  Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases.

Authors:  David Scheie; Torstein R Meling; Milada Cvancarova; Kari Skullerud; Sverre Mørk; Knut Lote; Tor J Eide; Eirik Helseth; Klaus Beiske
Journal:  Neuro Oncol       Date:  2011-08-19       Impact factor: 12.300

Review 5.  Can artificial intelligence overtake human intelligence on the bumpy road towards glioma therapy?

Authors:  Precilla S Daisy; T S Anitha
Journal:  Med Oncol       Date:  2021-04-03       Impact factor: 3.064

6.  Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.

Authors:  Fabio M Iwamoto; Linda Nicolardi; Alexis Demopoulos; Violetta Barbashina; Paulo Salazar; Marc Rosenblum; Adília Hormigo
Journal:  J Neurooncol       Date:  2008-03-15       Impact factor: 4.130

7.  Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes.

Authors:  K E Emblem; D Scheie; P Due-Tonnessen; B Nedregaard; T Nome; J K Hald; K Beiske; T R Meling; A Bjornerud
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

8.  Co-polysomy of chromosome 1q and 19p predicts worse prognosis in 1p/19q codeleted oligodendroglial tumors: FISH analysis of 148 consecutive cases.

Authors:  Xiaohui Ren; Haihui Jiang; Xiangli Cui; Yong Cui; Jun Ma; Zhongli Jiang; Dali Sui; Song Lin
Journal:  Neuro Oncol       Date:  2013-07-16       Impact factor: 12.300

9.  Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.

Authors:  Huiling He; Wei Li; Pearlly Yan; Ralf Bundschuh; Jackson A Killian; Jadwiga Labanowska; Pamela Brock; Rulong Shen; Nyla A Heerema; Albert de la Chapelle
Journal:  Thyroid       Date:  2018-05-16       Impact factor: 6.568

10.  Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.

Authors:  Leonard Sunwoo; Seung Hong Choi; Roh-Eul Yoo; Koung Mi Kang; Tae Jin Yun; Tae Min Kim; Se-Hoon Lee; Chul-Kee Park; Ji-Hoon Kim; Sun-Won Park; Chul-Ho Sohn; Jae-Kyung Won; Sung-Hye Park; Il Han Kim
Journal:  Neuroradiology       Date:  2015-08-01       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.